Saxenda safety under the microscope: new study monitors side effects in Real-World patients
NCT ID NCT02773355
First seen Apr 25, 2026 · Last updated Jun 22, 2026 · Updated 8 times
Summary
This completed study looked at how well doctors can detect serious and non-serious side effects of the weight-loss drug Saxenda (liraglutide) in 27 Mexican patients with obesity. The main goal was to track cases of pancreatitis and other possible drug reactions. Patients took Saxenda as part of their normal care, and researchers recorded any adverse events that came up.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro de Investigacion Clinica Endocrinologica de Jalisco
Guadalajara, Jalisco, 44670, Mexico
-
Especialidades Médicas del Bosque
Guadalajara, Jalisco, 44520, Mexico
-
Hospital Angeles de Puebla
Puebla City, 72190, Mexico
-
Hospital Angeles de las Lomas
México, State of Mexico, 52763, Mexico
-
Hospital Bite Medica
Mexico City, México, D.F., 01330, Mexico
-
Hospital CIMA Hermosillo
Hermosillo, Sonora, 83270, Mexico
-
Hospital HMG Coyoacan
Mexico City, México, D.F., 04380, Mexico
-
Hospital San Angel Inn
Mexico City, México, D.F., 03339, Mexico
-
Hospital San Angel Inn_Mexico City
Mexico City, México, D.F., 06700, Mexico
-
Investigación Clínica Especializada, S.C.
Guadalajara, Jalisco, 44600, Mexico
-
Medica Sur
Mexico City, 14050, Mexico
-
Torre Médica Dalinde
Mexico City, México, D.F., 06760, Mexico
-
Unidad Médica Dentistas
Guadalajara, Jalisco, 44679, Mexico
-
Zrii de México Ejecutivo Independiente
Monterrey, Nuevo León, 66220, Mexico
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
liraglutide (Saxenda)
What this could lead to
If successful, this could improve how doctors monitor and catch side effects of Saxenda in real-world settings, leading to safer use for obesity.
What could go wrong
This is a small, observational study with only 27 patients, so results may not apply broadly. It does not test if Saxenda works for weight loss, only safety monitoring.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.